World’s first intra nasal vaccine iNCOVACC from Bharat Biotech receives approval
iNCOVACC was developed in partnership with Washington University St. Louis, which had designed and developed the recombinant adenoviral vectored constructs and evaluated them in preclinical studies for efficacy